The great Msb short unwind, page-80

I don't know if the mistakes you outline were made but I agree that they could of made those mistakes. And I agree with one mistake in particular, but as with you, I have no way of being sure of anything because the market has not been informed of any of it.

Some of your post is nonsense. I don't care to illuminate it - I don't care if you don't see your own nonsense.




This comment of yours is a real peach though:

"I personally think that allowing a company's IP to beholden to debt is not in the interest of shareholders as its changes the lens to maintaining or growing IP value at all costs."

The IP comes first (generally), then the product, then the trials, then the approvals.

Do you want MSB to get the approvals before the IP or before they make the product?

You want risk free Biostock - good luck! Buy CSL at today's price then!